share_log

沃森生物(300142.SZ)：目前公司RQ3033疫苗正在积极申请获批上市

Watson Biotech (300142.SZ): Currently, the company's RQ3033 vaccine is actively applying for approval for marketing

Gelonghui Finance ·  Apr 17 19:31

Gelonghui, April 18 | Watson Biotech (300142.SZ) said on the investor interactive platform that currently the company's RQ3033 vaccine is actively applying for approval for listing (including conditional listing), but the exact timing is subject to regulatory approval. The company continues to monitor the mutation of the coronavirus strain and promotes the development of iterative products through immunogenic bridging and other methods in accordance with the overall deployment of the country. If approved for listing in the future (including conditional listing), it is expected to have a positive impact on the company's business performance.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment